Investigations on Binding Pattern of Kinase Inhibitors with PPAR<i>γ</i>: Molecular Docking, Molecular Dynamic Simulations, and Free Energy Calculation Studies

<div>Structures of PPAR<i>γ</i> full-agonist rosiglitazone and FDA approved kinase inhibitors.</div>

PPAR Research

fig1

Figure 1

Figure 1: Investigations on Binding Pattern of Kinase Inhibitors with PPAR<i>γ</i>: Molecular Docking, Molecular Dynamic Simulations, and Free Energy Calculation Studies 

Figure 1 | Investigations on Binding Pattern of Kinase Inhibitors with PPARγ: Molecular Docking, Molecular Dynamic Simulations, and Free Energy Calculation Studies 